| Characteristic | Lot release volume in million doses |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Sources
Release date
February 2019
Region
China
Survey time period
2013 to 2017
Supplementary notes
*Forecast.
Vaccines in the public market are commercially purchased by provincial Chinese Center for Disease Control and Prevention (CDCs) at relatively low prices and are available free of charge to the public. Vaccines in the private market are purchased by the public at their own expense.
Citation formats









